Thank you to all who attended this inaugural event, a training session on "๐๐ถ๐ณ๐ณ๐ฆ๐ฏ๐ต ๐๐ฉ๐ข๐ญ๐ญ๐ฆ๐ฏ๐จ๐ฆ๐ด ๐ช๐ฏ ๐๐ณ๐ฐ๐ด๐ต๐ข๐ต๐ฆ ๐๐ข๐ฏ๐ค๐ฆ๐ณ," organized by Quibim. It was an excellent opportunity to learn from experts and explore innovative tools to improve daily practice in this critical area. We look forward to hosting more events that spark valuable discussions and knowledge exchanges for advancing patient care. Special thanks to: Kai Vilanova MD, PhD, Richard Mast, Andreu Antolรญn Redondo, Polina Rudenko, pau montesinos, Milagros Otero-Garcรญa, Jeronimo Barrera Ortega, Juan Carlos Casanova, Paula Pelechano Gรณmez, Bernardino Miรฑana Lรณpez, MD PhD, Antonio Josรฉ Conde Moreno MD PhD MSc, Ana Jimenez Pastor, Encarna Sรกnchez Bernabรฉ, David Bazaga, Octavio Herranz Monge, Adriana Arpa, Javier Pizcueta Pastor, Josรฉ Cristรณbal Barrabรฉs Santa Bรกrbara, Lara Hernรกndez, Claire Palacin and รngel Alberich-Bayarri #ProstateCancer #healthcare
The biggest annual radiology event, #RSNA2024, is just around the corner! Under the theme โBuilding Intelligent Connections,โ this event becomes the perfect occasion to explore how to intentionally create the right connections between people and technology. ๐ Find us and our advanced medical imaging solutions at booth 5115. In the meantime, you can book a demo by clicking here: https://lnkd.in/dirvn7w3 #RSNA24 #MedicalImaging #Radiology
"Introducing a five-year screening programme for high-risk groups aged 45-69, using the current clinical pathway results in a positive socio-economic impact of ยฃ54m". This is one of the main claims of the Prostate Cancer Research report published today โSocio-economic impact of prostate cancer screeningโ, conducted by Deloitte. This analysis, in which Quibim has collaborated, highlights the economic and health benefits of improved screening practices to reduce healthcare costs and enhance patient outcomes. We were honored to attend the official launch in the House of Commons. Our thanks to Prostate Cancer Research (PCR), David Lammy Secretary of State for Foreign, Commonwealth and Development Affairs, James Cleverly Member of Parliament for the Braintree constituency and Josh Babarinde OBE CF MP of Parliament for Eastbourne for the invitation. We hope this report helps to elevate the importance of early #ProstateCancer screening.
At the Personalized Medicine Coalition conference, the conversations have been nothing short of inspiring. We could not be more grateful to the speakers that participated in "๐๐ณ๐ข๐ฏ๐ด๐ง๐ฐ๐ณ๐ฎ๐ช๐ฏ๐จ ๐๐ต๐ข๐ฏ๐ฅ๐ข๐ณ๐ฅ-๐ฐ๐ง-๐๐ข๐ณ๐ฆ ๐๐ฎ๐ข๐จ๐ช๐ฏ๐จ ๐ช๐ฏ๐ต๐ฐ ๐๐ณ๐ฆ๐ค๐ช๐ด๐ช๐ฐ๐ฏ ๐๐ช๐ข๐จ๐ฏ๐ฐ๐ด๐ต๐ช๐ค๐ด" talk, where our CEO & Co-Founder Dr. รngel Alberich-Bayarri had the chance to speak with Chiranjiv Singh, Megan Nacar and Okan Ekinci, MD MBA. A big thank you also to the panelists for the inspiring discussion on "๐๐ช๐ด๐ช๐ฐ๐ฏ๐ด ๐ง๐ฐ๐ณ ๐๐ ๐ข๐ฏ๐ฅ ๐ต๐ฉ๐ฆ ๐๐ถ๐ต๐ถ๐ณ๐ฆ ๐ฐ๐ง ๐๐ฆ๐ณ๐ด๐ฐ๐ฏ๐ข๐ญ๐ช๐ป๐ฆ๐ฅ ๐๐ฆ๐ฅ๐ช๐ค๐ช๐ฏ๐ฆ," and to the PMC organization for this journey! #PMC #AIinHealthcare #PersonalizedMedicine #PrecisionMedicine
"Quibim? What an interesting name! Does it mean anything?" It might be one of the most frequently asked questions when we introduce ourselves. But since giving it all away wouldn't be much fun, we've prepared a little quiz with answers on the last slide! ๐ How many letters did you guess? #Quibim #MedicalImage #Quiz
Tomorrow, the annual Personalized Medicine Coalition conference will begin in Boston, and at Quibim, we are more than proud to be among the event's sponsors. Catch our team for lunch in our designated room 217 from 12:30 to 1:30 PM for the talk "๐๐ณ๐ข๐ฏ๐ด๐ง๐ฐ๐ณ๐ฎ๐ช๐ฏ๐จ ๐๐ต๐ข๐ฏ๐ฅ๐ข๐ณ๐ฅ-๐ฐ๐ง-๐๐ข๐ณ๐ฆ ๐๐ฎ๐ข๐จ๐ช๐ฏ๐จ ๐ช๐ฏ๐ต๐ฐ ๐๐ณ๐ฆ๐ค๐ช๐ด๐ช๐ฐ๐ฏ ๐๐ช๐ข๐จ๐ฏ๐ฐ๐ด๐ต๐ช๐ค๐ด". During this session, renowned key industry leaders will explore how AI technologies can query the divergent effects of preventive and treatment interventions across a previously unimaginable range of data points. You can also engage with our CEO & Co-Founder, Dr รngel Alberich-Bayarri, in the 4:30 PM panel discussion on "๐๐ช๐ด๐ช๐ฐ๐ฏ๐ด ๐ง๐ฐ๐ณ ๐๐ ๐ข๐ฏ๐ฅ ๐ต๐ฉ๐ฆ ๐๐ถ๐ต๐ถ๐ณ๐ฆ ๐ฐ๐ง ๐๐ฆ๐ณ๐ด๐ฐ๐ฏ๐ข๐ญ๐ช๐ป๐ฆ๐ฅ ๐๐ฆ๐ฅ๐ช๐ค๐ช๐ฏ๐ฆ." Check out the full program at: https://lnkd.in/dzB6E7mM #PMC2024 #PersonalizedMedicine
๐ฉบ From its contribution to cancer diagnoses to the effectiveness of screening methods in reducing mortality rates, radiology is integral to modern medicine, playing a critical role in diagnosing and managing diseases. On the occasion of #WorldRadiologyDay, we had the opportunity to interview Dr Jacob J. Visser, one of our advisors, to focus on advances in radiology technology and their implications for patient care. ๐ Read the full conversation here: https://lnkd.in/d_jXBHAQ #Radiology #Health #PatientCare #AIinHealth
๐๏ธ Mark your calendar for the Global Health Webinar on November 26, 2024. Organized by CERN Innovation Partnerships, this public event will reveal the results of its recent workshop, where health professionals, policymakers and experts addressed pressing global health challenges. Join this conversation to hear the conclusions that were drawn from plenty of speakers, included our CEO and co-founder, รngel Alberich-Bayarri, who presented innovative ideas and potential collaborations to advance global health.
After the severe storms and flooding in Valencia, radiologists in the region and our CEO have spoken out about the impact in life and work. Read the full article here: https://lnkd.in/d4P5he-m
Sir Chris Hoy, six-time Olympic champion, has shared his terminal diagnosis of #ProstateCancer with a powerful message: initiate early screening for men with a strong family history. โCatch it before they need major treatment,โ he urges to lower the age of detection to save lives. This call comes at an opportune time, as the largest prostate cancer screening trial in 20 years, the TRANSFORM trial, is underway in the UK. This initiative is an ambitious effort to determine the most effective #screening methods and offers a critical opportunity to reshape early detection. โก๏ธ https://lnkd.in/dQxJV5vu
